Bisrat G. Debeb

Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions.

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.

Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.

Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.

Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.

High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.

Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.

Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.

Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.

MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.

miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.

Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response.

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.

Inflammatory breast cancer: a model for investigating cluster-based dissemination.

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival.

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference.

Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.

Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis.

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer.